Artelo Biosciences, Inc. · NASDAQ:ARTL
Armistice Capital, LLC reported a 9.99% stake in Artelo Biosciences, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Armistice Capital, LLC reported a 9.99% stake in Artelo Biosciences, Inc., 235,823 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 235,823
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 235,823 |
| Steven Boyd | 9.99% | 235,823 |